Intro to Cancer Therapeutics Flashcards

1
Q

Epochs of Cancer treatment

A

Surgery, Radiation, Cytotoxic chemotherapy, combination chemotherapy, growth factor antagonism, specific immune therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

adjuvant

A

systemic therapy given after surgery as an aid to achieving cure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

neo-adjuvant

A

pre-operative therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

single most conceptual advance in cancer therapy

A

combination of local and systemic therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Systemic therapies are usefully classified as

A

chemotherapy (poisons that inhibit mitosis or induce apoptosis)
Signal transduction inhibitors
Immune therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Central dogma

A

DNA – RNA – protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Most pharmacology impacts

A

proteins (then intermediary metabolism) - least DNA and RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where does protein regulation come at protein level

A
Protein-Protein interactions
Glycosylation
Phosphorylation
Proteolysis
Degradation (Ubiquitin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where do you regulate DNA to regulate proteins

A
Promoter
	•Transcription factors
	•Constitutive Expression
	•Silencing by Methylation
Chromatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how do you regulate RNA to regulate protein

A

Alternate splicing
iRNA
shRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pathologic alterations of DNA

A
Viral Insertion
Translocation
Mutation
	Gain-of-function
	Loss-of-function
	Silent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Phases of mitosis

A
prophase
prometaphase
metaphase
anaphase
telophase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

possible outcomes of mitotic arrest

A

(unattached kinetochores) – >
chronic arrest
adaptation, mitotic death

survival, apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cancers are diseases of rapid/slow growth

A

Diseases of slow accumulation from failure to response to apoptotic signals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

2 pathways of apoptosis

A

Intrinsic

FAS-mediated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Intrinsic apoptotic pathway

A

tbid - Cyto C –> casp 9 + apaf-1 –> apoptosome –> cleaved casp 9 –> cleaved casp 3 –> casp 7, apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

FAS mediated pathway

A

Fas-ligand + receptor –> cleaved casp 8 – casp 3– casp 7, PARP – apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

most drugs work where

19
Q

fundamental, highly regulated process important both for neoplasia and sensitivity to chemotherapy

20
Q

what is cancer

A
dysregulated growth characterized by 
loss of orientation and contact inhibition
failure to respect anatomic boundaries
immune evasion
promotion of angiogenesis
21
Q

what does cancer arise from

A

Arises from unbalanced growth promoting signals (“oncogenes”) with growth inhibitors (“tumor suppressors”)

22
Q

human cancers are complex “organs” with

A

malignant cells, stromal cells, vasculature & immune infiltrates. They typically have very high interstitial pressure, low oxygen tension and low pH

23
Q

how are cancers currently classified

A

Currently cancers are classified by tissue type of origin:
• Epithelial (carcinoma) ca. 70% of all cancers, named by anatomic site
• Stromal (sarcoma)
• Hematologic (leukemia, lymphoma, plasma cell dyscrasia)
• Germ Cell Tumors

24
Q

cancer classification smart way

A
Soon, cancers will be classified on the basis of biology: 
What is driving proliferation
What is inhibiting apoptosis
What is promoting invasion
What is promoting immune evasion
etc.
25
order of drug testing
``` biochemical assays in cell culture at least 2 non-human species Phase 1 - dose safety Phase 2 - effective? Phase 3 - compare ```
26
monoclonal antibodies - name
mab
27
proteasome inhibitors - name
omib
28
tyrosine kinase inhibitors - name
nib
29
mTor inhibitors
limus
30
antiandrogens
amide
31
nucleoside analogs
abine
32
Phase I clinical trials usually include
pharmacokinetics | pharmacodynamics
33
pharmacokinetics
the characterization of the distribution, metabolism and excretion of drugs: How the body affects the drug
34
pharmacodynamics
the characterization of how the drug interacts with a living system: How the drug affects the body
35
aim of phase I clinical trials
dose limiting toxicity (DLT)
36
how many in phase I clinical trials
37
grades of toxicity
grade 1 events have no physiologic or clinical consequence Grade 2 events are physiologically relevant Grade 3 events are potentially associated with major morbidity (hospitalization, intensive treatment, etc.) Grade 4 events are life threatening CTAE v4.0
38
Phase II clinical trials goal
Scientific and statistical goal is to define the rate of "benefit" in a defined population
39
phase II number of patients
30-60
40
Prognostic factors
tumor size and nodal status (now) ``` PMN:Lymphocyte ration Performance Status Inflammatory markers such as acute phase reactants: low albumin high ferritin high platelets elevated c-reactive protein Erythrocyte sedimentation rate (ESR) elevated beta-2 microglobulin elevated IL-6 Age Particular genetic lesions ```
41
Phase III goal
formally compare two or more treatments (or strategies) using a definitive end-point such as survival time
42
Phase III number of people
300-1200
43
phase III requires what skill
equipoise (Lucky you test)
44
All treatment arms in a phase 3 trial must be defensible as _______.
reasonable